|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the SYT 20-F filed Mar 1, 2006. Additional US GAAP disclosures Earnings per share The following is a reconciliation of the numerators and denominators of the basic and diluted earnings per share computation for the years ended December 31, 2005, 2004 and 2003.
The following numbers of potential shares outstanding at the years ended December 31, 2005, 2004 and 2003 have not been included in the computation of diluted earnings per share, because the effect would have been antidilutive:
The weighted-average diluted number of shares is lower than the corresponding IFRS number because, for US GAAP, in accordance with SFAS 123(R), the hypothetical share issuance proceeds that Syngenta would have received if all options outstanding during the period had been exercised, must include the excess tax benefits that Syngenta would have received from claiming related tax deductions based on the average share price during the period. For IFRS, the calculation of the hypothetical share issuance proceeds does not include this tax benefit in accordance with IFRS 2. For this reason, the dilutive effect of these options is lower in the US GAAP calculation. Amortization of intangible assets Amortization expense under US GAAP for intangible assets, excluding goodwill was US$290 million, US$283 million and US$276 million for the years ended December 31, 2005, 2004 and 2003, respectively. The estimated amortization expense for intangible assets under US GAAP for each of the five years following the balance sheet date is as follows:
F-87 This excerpt taken from the SYT 20-F filed Mar 16, 2005. Additional US GAAP disclosures Earnings per share The following is a reconciliation of the numerators and denominators of the basic and diluted earnings per share computation for the years ended December 31, 2004, 2003 and 2002.
An option over 4.5 million ordinary shares with an exercise price of CHF 138 per share was outstanding as from February 10, 2004 and remained outstanding as of December 31, 2004. It has been excluded from the computation of diluted earnings per share as its effect would have been antidilutive. Options to purchase 1.7 million ordinary shares with exercise prices ranging from CHF 76.5 to CHF 98.0 per share were outstanding during 2003, but were excluded from the computation of diluted earnings per share, as their effect would have been antidilutive. In 2002, as a net loss was incurred, all options outstanding were considered antidilutive for US GAAP. Amortization of intangible assets Amortization expense under US GAAP for intangible assets, excluding goodwill was US$283 million, US$276 million and US$296 million for the years ended December 31, 2004, 2003 and 2002, respectively. The estimated amortization expense for intangible assets under US GAAP for each of the five years following the balance sheet date is as follows:
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for SYT: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||
